Duke Study: Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%
Results are being presented today at the International Conference on Brain Tumor Research and Therapy in Norway and published in The New England Journal of Medicine.
Four Things to Know About Adult Scoliosis
Shaffrey Named Spine Chief
Thelma's Story: Breaking New Ground
Was it Alzheimer’s disease? Vertigo? Thelma Cooper didn’t know what was causing her blackouts, memory lapses, and debilitating nausea, and the lack of answers drove her into a depression.
Treatment Advances Give Hope to People with Brain Metastases
Lisa VanTress didn’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016.
Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.
Duke Neurosurgery Quality Initiative Leads to Decreased Patient Mortality
As a Buddhist priest, Codd finds deeper connection with patients
Patrick Codd, MD, a Duke neurosurgeon, has been practicing Zen for two decades.
Karikari Receives Excellence in Professionalism Award
Duke neurosurgeon Isaac Karikari, MD, received the Excellence in Professionalism Award at the Duke University School of Medicine’s spring 2018 faculty meeting.